BIOS Fund III, LPinsider trades
In SEC Form 4 filings, BIOS Fund III, LP is listed as Director, 10% owner of Actuate Therapeutics, Inc. (ACTU). BIOS Fund III, LP reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 30.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ACTUActuate Therapeutics, Inc. | Director, 10% owner | 13 | Oct 30 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-30
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 64,995 | $0.53 | $34,610 | 64,995 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 87,743 | $0.53 | $46,723 | 87,743 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 682,885 | $0.53 | $363,636 | 682,885 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 194,984 | $0.53 | $103,829 | 194,984 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 368,304 | $0.53 | $196,122 | 368,304 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 47,972 | $0.53 | $25,545 | 47,972 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 82,018 | $0.53 | $43,675 | 82,018 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 36,056 | $0.53 | $19,200 | 36,056 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 269,342 | $0.53 | $143,425 | 269,342 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 82,454 | $0.53 | $43,907 | 82,454 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 133,073 | $0.53 | $70,861 | 133,073 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 824,012 | $0.53 | $438,786 | 824,012 | No | Form 4 |
| ACTUActuate Therapeutics, Inc. | Oct 28 | Oct 30 | A · derivative | 126,162 | $0.53 | $67,181 | 126,162 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.